Skip to content

Janssen’s Erleada Will be the First Participant in FDA’s Clinical Data Summary Pilot Program

Janssen’s Erleada Will be the First Participant in FDA’s Clinical Data Summary Pilot Program Headshot

Jason J. Jardine

Appreciated for his strategic analysis and solutions that fit each client’s specific needs, Jason Jardine represents a diverse clientele in all aspects of intellectual property acquisition, protection and enforcement across...